Figure 3

Overall survival according to treatment strategy. Kaplan–Meier overall survival estimates for patients still under study at 200 days (landmark analysis) who underwent valve interventions within 200 days (solid line) vs. patients who had not (yet) undergone valve intervention up to 200 days (dashed line).